13-100268802-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000282.4(PCCA):c.914+19A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.987 in 1,558,632 control chromosomes in the GnomAD database, including 760,753 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.93 ( 66742 hom., cov: 32)
Exomes 𝑓: 0.99 ( 694011 hom. )
Consequence
PCCA
NM_000282.4 intron
NM_000282.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.760
Publications
7 publications found
Genes affected
PCCA (HGNC:8653): (propionyl-CoA carboxylase subunit alpha) The protein encoded by this gene is the alpha subunit of the heterodimeric mitochondrial enzyme Propionyl-CoA carboxylase. PCCA encodes the biotin-binding region of this enzyme. Mutations in either PCCA or PCCB (encoding the beta subunit) lead to an enzyme deficiency resulting in propionic acidemia. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
PCCA Gene-Disease associations (from GenCC):
- propionic acidemiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 13-100268802-A-G is Benign according to our data. Variant chr13-100268802-A-G is described in ClinVar as Benign. ClinVar VariationId is 92765.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.931 AC: 141552AN: 152124Hom.: 66706 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
141552
AN:
152124
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.981 AC: 245829AN: 250532 AF XY: 0.986 show subpopulations
GnomAD2 exomes
AF:
AC:
245829
AN:
250532
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.993 AC: 1396161AN: 1406388Hom.: 694011 Cov.: 23 AF XY: 0.994 AC XY: 699020AN XY: 703480 show subpopulations
GnomAD4 exome
AF:
AC:
1396161
AN:
1406388
Hom.:
Cov.:
23
AF XY:
AC XY:
699020
AN XY:
703480
show subpopulations
African (AFR)
AF:
AC:
24428
AN:
32404
American (AMR)
AF:
AC:
43980
AN:
44654
Ashkenazi Jewish (ASJ)
AF:
AC:
25759
AN:
25790
East Asian (EAS)
AF:
AC:
39410
AN:
39410
South Asian (SAS)
AF:
AC:
85084
AN:
85148
European-Finnish (FIN)
AF:
AC:
53380
AN:
53380
Middle Eastern (MID)
AF:
AC:
5596
AN:
5668
European-Non Finnish (NFE)
AF:
AC:
1060924
AN:
1061392
Other (OTH)
AF:
AC:
57600
AN:
58542
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
397
793
1190
1586
1983
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20302
40604
60906
81208
101510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.930 AC: 141644AN: 152244Hom.: 66742 Cov.: 32 AF XY: 0.932 AC XY: 69376AN XY: 74462 show subpopulations
GnomAD4 genome
AF:
AC:
141644
AN:
152244
Hom.:
Cov.:
32
AF XY:
AC XY:
69376
AN XY:
74462
show subpopulations
African (AFR)
AF:
AC:
31479
AN:
41480
American (AMR)
AF:
AC:
14872
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
3469
AN:
3472
East Asian (EAS)
AF:
AC:
5179
AN:
5180
South Asian (SAS)
AF:
AC:
4821
AN:
4826
European-Finnish (FIN)
AF:
AC:
10624
AN:
10624
Middle Eastern (MID)
AF:
AC:
289
AN:
294
European-Non Finnish (NFE)
AF:
AC:
67977
AN:
68036
Other (OTH)
AF:
AC:
2022
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
409
819
1228
1638
2047
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
902
1804
2706
3608
4510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3422
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Jun 11, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Propionic acidemia Benign:4
Jul 01, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:3
Feb 29, 2016
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.